Loading…
Turn Therapeutics Inc. is projected to rise to $12.20 by 2027, a +46% move from its current price of $8.36. TTRX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $7.93 | $8.37 | $8.83 | +0.09% |
| Aug 4 | $7.76 | $8.38 | $9.04 | +0.18% |
| Aug 5 | $7.63 | $8.38 | $9.21 | +0.27% |
| Aug 6 | $7.53 | $8.39 | $9.35 | +0.37% |
| Aug 7 | $7.44 | $8.40 | $9.48 | +0.46% |
| Aug 8 | $7.36 | $8.41 | $9.60 | +0.55% |
| Aug 9 | $7.29 | $8.41 | $9.71 | +0.64% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $7.29 | $8.41 | $9.71 | +0.64% |
| Week 2 | $6.91 | $8.47 | $10.37 | +1.29% |
| Week 3 | $6.65 | $8.52 | $10.92 | +1.94% |
| Week 4 | $6.44 | $8.58 | $11.42 | +2.59% |
| Week 5 | $6.26 | $8.63 | $11.89 | +3.25% |
| Week 6 | $6.11 | $8.69 | $12.34 | +3.91% |
| Week 7 | $5.98 | $8.74 | $12.77 | +4.58% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Turn Therapeutics Inc. operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye.
Its delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses.
The company was formerly known as Global Health Solutions, Inc and changed its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Turn Therapeutics Inc. (TTRX) trades at $8.36 and has a market capitalization of $249.03M, ranking 3610.
The forecast shows a neutral start in 2026 with an average price of $8.36, a min of $3.12 and a max of $13.72, and 0 ROI.
From 2027 onward, the outlook turns bullish with rising averages and double-digit ROIs, including 2027 avg $12.20 and ROI 46%, 2028 avg $13.41 and ROI 60.4%, and 2029 avg $16.52 with ROI 97.6%.
The long-range forecast projects substantial upside in later years, with 2032 avg $26.98 and ROI 222.7, 2033 avg $31.44 and ROI 276.1, 2034 avg $35.26 and ROI 321.7, 2035 avg $39.01 and ROI 366.6, 2040 avg $75.03 and ROI 797.5, and 2050 avg $116.73 and ROI 1296.3.
A major floor 62.7% below — a decisive break under it would weaken the trend.
The nearest floor, 31.0% below — buyers have tended to step in here.
The nearest ceiling, 21.8% above — a clean break opens room to run.
A major ceiling 49.7% above — clearing it would confirm fresh momentum.
Key TTRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TTRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.90 | Buy | $8.21 | Buy |
| MA 10 | $8.74 | Sell | $8.44 | Sell |
| MA 20 | $8.95 | Sell | $8.38 | Sell |
| MA 50 | $7.14 | Buy | $7.31 | Buy |
| MA 100 | $5.37 | Buy | $6.19 | Buy |
| MA 200 | $4.67 | Buy | $5.61 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.95 | Neutral |
| Stoch RSI (14) | 28.61 | Neutral |
| CCI (20) | -55.98 | Neutral |
| Williams %R (14) | -66.18 | Info |
| MACD (12,26,9) | -0.29 | Sell |
| ROC (12) | -12.73 | Sell |
| Bollinger %B (20,2) | 0.32 | Neutral |
| Stochastic %K (14) | 33.82 | Neutral |
| TRIX (15) | 1.18 | Buy |
| Awesome (5,34) | -0.02 | Sell |
| Ultimate (7,14,28) | 37.17 | Neutral |
| Momentum (10) | -0.76 | Sell |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 7.58 | Buy |
| ADX (14) | 25.91 | Buy |
| ATR (14) | 0.41 | Info |
The 30-day technical picture is bullish.
RSI14 is 50; SMA50 is $7.14 and SMA200 is $4.67. Support is $5.77 and resistance is $10.18.
The 30-day range runs from $5.85 to $11.95.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.12 | $8.36 | $13.72 | 0% | Neutral | |
| $8.12 | $12.20 | $19.86 | +46% | Bullish | |
| $8.08 | $13.41 | $23.75 | +60% | Bullish | |
| $9.13 | $16.52 | $31.16 | +98% | Bullish | |
| $7.61 | $14.95 | $29.69 | +79% | Bullish | |
| $7.69 | $16.35 | $33.91 | +96% | Bullish | |
| $12.14 | $26.98 | $58.14 | +223% | Bullish | |
| $14.15 | $31.44 | $70.11 | +276% | Bullish | |
| $15.87 | $35.26 | $81.08 | +322% | Bullish | |
| $17.55 | $39.01 | $89.71 | +367% | Bullish | |
| $33.76 | $75.03 | $172.56 | +797% | Bullish | |
| $52.53 | $116.73 | $268.47 | +13.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $3.12 | $8.36 | $11.70 | +0.00% |
| September 2026 | $7.53 | $9.41 | $12.41 | +12.51% |
| October 2026 | $7.13 | $9.09 | $12.32 | -3.40% |
| November 2026 | $7.19 | $9.32 | $12.92 | +2.62% |
| December 2026 | $7.37 | $9.71 | $13.72 | +4.10% |
Click any year to see its month-by-month TTRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, TTRX is projected to trade between $3.12 and $13.72, averaging $8.36 — a potential gain of 0% from today's $8.36. A consolidation phase looks the most probable path here.
Turn Therapeutics Inc.'s 2027 outlook centres on $12.20, within a $8.12 to $19.86 range. That is up +46% on the projected 2026 average. That marks a +46% change versus current levels. Momentum favours further upside here.
By 2028, TTRX could reach as high as $23.75, with a base case around $13.41 and support toward $8.08 — roughly +60% from $8.36. Buyers look set to stay in control over this stretch.
Expect TTRX to range from $9.13 to $31.16 through 2029. The $16.52 average target implies a +98% move from current prices. That is up +23% on the projected 2028 average. Momentum favours further upside here.
The TTRX price prediction for 2030 points to an average of $14.95 (low $7.61, high $29.69) — a potential gain of +79% on today's $8.36. Buyers look set to stay in control over this stretch.
In 2031, TTRX is projected to trade between $7.69 and $33.91, averaging $16.35 — a potential gain of +96% from today's $8.36. That is up +9% on the projected 2030 average. Momentum favours further upside here.
Turn Therapeutics Inc.'s 2032 outlook centres on $26.98, within a $12.14 to $58.14 range. That is up +65% on the projected 2031 average. That marks a +223% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, TTRX could reach as high as $70.11, with a base case around $31.44 and support toward $14.15 — roughly +276% from $8.36. Momentum favours further upside here.
Expect TTRX to range from $15.87 to $81.08 through 2034. The $35.26 average target implies a +322% move from current prices. That is up +12% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The TTRX price prediction for 2035 points to an average of $39.01 (low $17.55, high $89.71) — a potential gain of +367% on today's $8.36. Momentum favours further upside here.
In 2040, TTRX is projected to trade between $33.76 and $172.56, averaging $75.03 — a potential gain of +797% from today's $8.36. That is up +92% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Turn Therapeutics Inc.'s 2050 outlook centres on $116.73, within a $52.53 to $268.47 range. That is up +56% on the projected 2040 average. That marks a +13.0x change versus current levels. Momentum favours further upside here.
Investing $1,000 in TTRX today (≈ 119.617225 TTRX) could be worth
$13,962.46
+$12,962.46 (+1296%) by 2050 · US Dollar
Based on the average projected TTRX price of $116.73 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TTRXwould be worth at today's price.
$1,000 invested in TTRX on Oct 8, 2025 (≈ 142.857143 TTRX) would be worth
$1,194.29
+$194.29 (+19.4%) today · 1.19× · US Dollar
Based on a TTRX entry price of $7 vs. today's $8.36.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $8.54 | $978.92 | -2.1% |
| 1 month ago | $6.85 | $1,220.44 | +22.0% |
| 3 months ago | $3.8 | $2,200 | +120.0% |
| 6 months ago | $4.18 | $2,000 | +100.0% |
| All time ago | $7 | $1,194.29 | +19.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TTRX forecast.
Our base-case forecast reaches $17.00 around 2032.
Implied market cap at $17.00: $506.4M
The multi-year forecast shows bullish sentiment across the horizon with strong upside. For 2030, the avg is $14.95 with ROI 78.8; 2040 shows avg $75.03 with ROI 797.5; 2050 shows avg $116.73 with ROI 1296.3.
Earlier years also project solid upside, with 2027 avg $12.20 (ROI 46), 2028 avg $13.41 (ROI 60.4), 2029 avg $16.52 (ROI 97.6), and 2031 avg $16.35 (ROI 95.6). The forecast later in the decade and into 2032–2035 shows increasingly large ROIs (e.g., 2032 ROI 222.7, 2033 ROI 276.1, 2034 ROI 321.7, 2035 ROI 366.6) alongside rising averages, followed by 2040 ROI 797.5 and 2050 ROI 1296.3.
These are estimates and not guarantees.
Tap a question to reveal the answer.
Avg $14.95 with a range from $7.61 to $29.69; ROI 78.8; sentiment BULLISH.
The forecast from 2027 onward is BULLISH with rising averages and ROIs, including 2027 avg $12.20, ROI 46; 2028 avg $13.41, ROI 60.4; 2029 avg $16.52, ROI 97.6; 2030 avg $14.95, ROI 78.8; 2031 avg $16.35, ROI 95.6; 2032 avg $26.98, ROI 222.7; 2033 avg $31.44, ROI 276.1; 2034 avg $35.26, ROI 321.7; 2035 avg $39.01, ROI 366.6; 2040 avg $75.03, ROI 797.5; 2050 avg $116.73, ROI 1296.3.
Yes — the forecast max in 2028 is $23.75, in 2029 is $31.16, and in 2030 is $29.69, indicating potential to exceed $20 in those years.
Current price is $8.36 and market cap is $249.03M.
Sentiment BULLISH; RSI14 50; SMA50 $7.14; SMA200 $4.67; Support $5.77; Resistance $10.18; 30-day range $5.85–$11.95.
Turn Therapeutics Inc. Community Discussion
0Share your Turn Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.